Table 3.
GI Percentage Reduction | ||||||
---|---|---|---|---|---|---|
Intervention |
Placebo |
|||||
Interval | % | SD | % | SD | P-value | |
All Patients |
Baseline to 30 days | 22.33 | 18.40 | 12.13 | 14.39 | 0.019* |
30 to 60 days | 10.74 | 20.17 | 7.34 | 15.62 | 0.395 | |
Baseline to 60 days | 33.07 | 19.01 | 19.47 | 16.57 | 0.005** | |
Patients with mild inflammation |
Baseline to 30 days | 17.15 | 17.15 | 5.57 | 10.55 | 0.007** |
30 to 60 days | 13.13 | 22.75 | 9.35 | 16.17 | 0.421 | |
Baseline to 60 days | 30.28 | 21.54 | 14.92 | 14.61 | 0.012* | |
Patients with moderate inflammation |
Baseline to 30 days | 34.40 | 16.03 | 27.46 | 9.72 | 0.122 |
30 to 60 days | 5.17 | 11.45 | 2.63 | 13.95 | 0.691 | |
Baseline to 60 days | 39.57 | 9.02 | 30.09 | 16.75 | 0.077 |
*P < 0.05 ** P < 0.01.